Prelude Capital Management’s Regenxbio RGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-82,321	Closed	-$676K	–	1338
2025 Q2	$676K	Sell	82,321 -30,199	-27%	-$253K	0.07%	360
2025 Q1	$805K	Buy	+112,520	New	+$837K	0.06%	361
2024 Q2	–	Sell	-21,565	Closed	-$454K	–	1450
2024 Q1	$454K	Buy	+21,565	New	+$384K	0.02%	675
2020 Q4	–	Sell	-2,017	Closed	-$56K	–	1865
2020 Q3	$56K	Hold	2,017	–	–	﹤0.01%	1091
2020 Q2	$74K	Buy	2,017 +2,013	+50,325%	+$75K	﹤0.01%	1039
2020 Q1	$0	Sell	4 -1,462	-100%	-$60.9K	﹤0.01%	1935
2019 Q4	$60K	Buy	+1,466	New	+$57.9K	﹤0.01%	1278
2019 Q2	–	Sell	-151	Closed	-$9K	–	2069
2019 Q1	$9K	Buy	+151	New	+$7.48K	﹤0.01%	1476
2018 Q4	–	Sell	-200	Closed	-$15K	–	2103
2018 Q3	$15K	Sell	200 -9,125	-98%	-$657K	﹤0.01%	1374
2018 Q2	$669K	Buy	9,325 +965	+12%	+$46.1K	0.04%	438
2018 Q1	$250K	Buy	+8,360	New	+$243K	0.02%	634
2017 Q4	–	Sell	-6,055	Closed	-$200K	–	1653
2017 Q3	$200K	Buy	6,055 +416	+7%	+$9.36K	0.02%	651
2017 Q2	$111K	Buy	5,639 +3,308	+142%	+$64.1K	0.01%	749
2017 Q1	$45K	Buy	+2,331	New	+$45K	﹤0.01%	1028